Bionomic builds advanced computational capabilities for multi-omics interpretation, protein function intelligence, and research acceleration for organizations that need serious technical credibility, not decorative AI branding.
We focus on the point where computational depth, biological context, and practical delivery meet.
Our innovation is built on more than 20 years of accumulated scientific knowledge, translating long-term research depth into practical capabilities for biotech, pharma, diagnostics, and advanced R&D teams. For clients, that means more reliable interpretation, stronger biological context, and analytical work grounded in proven scientific expertise rather than surface-level AI claims.
The publication record of our team demonstrates that depth across microbiome science, metagenomics, pathogen bioinformatics, protein modeling, and multimodal AI for protein function.
The strongest service-facing proof point. It shows the ability to turn complex biological knowledge into an interpretable computational product for real analytical use, which is directly aligned with Bionomic’s value proposition to clients.
View publicationThis is the clearest machine-learning and AI signal in the portfolio. It supports Bionomic’s positioning in protein intelligence, functional prediction, and scalable biological interpretation with modern multimodal modeling.
View preprintA very strong publication for drug-discovery credibility. It combines machine learning, QSAR modeling, and optimization for medicinal chemistry, making it one of the most commercially relevant papers for pharma-facing services.
View publicationThis demonstrates large-scale omics capability, robust data handling, and the ability to work with biologically complex environments. For clients, it supports confidence in Bionomic’s bioinformatics depth and pipeline maturity.
View publicationA landmark high-citation Nature paper that materially strengthens scientific trust. It is not the most direct service paper, but it adds major credibility through international-scale microbiome research and recognized impact.
View publicationA first-author paper that shows strength in computational genomics, regulatory-region analysis, and mechanistic biological interpretation. It supports Bionomic’s credibility in extracting functional insight from complex genomic systems.
View publicationAnother first-author publication that demonstrates genome-resolved microbial analysis, temporal biological interpretation, and rigorous work with dynamic multi-layer datasets. It reinforces trust in Bionomic’s handling of complex biological data.
View publicationThis is a strong early machine-learning paper with direct relevance to protein modeling. It adds technical depth in predictive modeling and strengthens the case for Bionomic’s long-standing capability in computational protein science.
View publicationThis adds an important drug-discovery and translational biology signal. It broadens the portfolio beyond omics and microbiology by showing involvement in biologically validated small-molecule research relevant to therapeutic development.
View publicationCombining transcriptomics, translatomics, and experimental context to create more coherent biological interpretation and stronger downstream decisions.
Applying advanced AI approaches to protein-function understanding, annotation support, and biologically relevant modeling workflows.
Enabling faster, more targeted research progress for biotech and pharma teams without sacrificing rigor, control, or scientific clarity.
Bionomic exists to turn complex biological data into usable intelligence. We design AI-driven systems that support condition-aware interpretation, protein-level insight, and more effective scientific decision-making. The goal is not more noise, more dashboards, or more hype. The goal is better research leverage, delivered with technical seriousness and enterprise-grade restraint.